Business Wire

CA-NETAPP

10.4.2024 19:01:45 CEST | Business Wire | Press release

Share
NetApp Partners with Google Cloud to Maximize Flexibility for Cloud Data Storage

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced an expansion of its partnership with Google Cloud to make it easier for organizations to leverage their data for generative AI (GenAI) and other hybrid cloud workloads. NetApp and Google Cloud are announcing the Flex service level for Google Cloud NetApp Volumes which supports storage volumes of nearly any size. NetApp is also releasing a preview of its GenAI toolkit reference architecture for retrieval-augmented generation (RAG) operations using Google Cloud Vertex AI platform.

More Flexible Data Storage Options for Google Cloud NetApp Volumes

Google Cloud and NetApp are announcing a new service level for NetApp Volumes called Flex that gives customers more granular control to adapt their storage and performance to match the exact needs of their cloud workloads.

“Increasing demand for data-intensive applications and insights has reinforced the need for a new approach to unified data storage that gives organizations the agility to move and store data wherever it is needed at any point in time,” said Pravjit Tiwana, Senior Vice President and General Manager, Cloud Storage at NetApp. “By extending our collaboration with Google Cloud, we’re delivering a flexible form factor that can be run on existing infrastructure across Google Cloud system without any tradeoffs to enterprise data management capabilities.”

With the addition of Flex, NetApp Volumes customers can choose from four service levels to leverage a fully managed file service built on NetApp ONTAPTM and operated by Google Cloud, including:

  • Standard: highly available, general-purpose storage with advanced data management capabilities and 16MiB/sec per TiB of performance, which is recommended to support workloads such as file shares, virtual machines (VMs), and DevTest environments.
  • Premium: highly available, high-performance storage with advanced data management capabilities and 64MiB/sec per TiB of performance, which is recommended for file shares, VMs, and databases.
  • Extreme: highly available, low-latency, high-throughput storage with advanced data management capabilities and 128MiB/sec per TiB of performance, which is recommended for Online Transaction Processing (OLTP) high-performance databases and low-latency applications.
  • Flex: highly available storage volumes with scalability from one GiB to 100TiB and up to one GiB/s of performance depending on the size of the underlying storage pool. This adaptable service level can support a wide variety of use cases, including AI.

“Google Cloud NetApp Volumes remains a critical component of every enterprise’s digital transformation strategy,” said Sameet Agarwal, GM/VP, Google Cloud Storage at Google Cloud. “Utilizing Google Cloud technologies, NetApp Volumes will power new capabilities that can improve how businesses operate and create real-world value for their organizations.”

The Flex service level will be generally available by Q2 2024 across 15 Google Cloud regions, expanding to the other Google Cloud regions by the end of 2024.

Unlocking Enterprise Data for Generative AI in Google Cloud

NetApp is also releasing a preview of its GenAI toolkit with support for NetApp Volumes. This offering, along with the accompanying reference architecture, speeds the implementation of RAG operations while enabling secure, consistent, and automated workflows that securely connect data stored in NetApp Volumes with Google Cloud Vertex AI platform. The result is a greater ability to generate unique, high-quality, and ultra-relevant insights and automations.

“As the intelligent data infrastructure company, we have unmatched capabilities to support data classification, tagging, mobility, and cloning for data wherever it lives so our customers can run efficient and secure AI data pipelines,” said Pravjit Tiwana, Senior Vice President and General Manager, Cloud Storage at NetApp. “Building on our partnership with Google Cloud to streamline RAG enables customers to tap into market-leading AI services and models to generate a unique competitive advantage.”

The NetApp GenAI toolkit helps optimize RAG processes with unique capabilities, including:

  • Common data footprint everywhere: NetApp ONTAP allows customers to easily include data from any environment to power their RAG efforts with common operational processes while reducing risk, cost, and time to results.
  • Automated classification and tagging: NetApp’s BlueXP classification service automatically tags data to support streamlined data cleansing for both the ingest and inferencing phases of the data pipeline, ensuring that the right data is used for queries and that sensitive data is not exposed to the model out of policy.
  • Fast, scalable snapshots: ONTAP Snapshot delivers near-instant creation of space-efficient, in-place copies of vector stores and databases, allowing immediate roll back to a previous version if data is corrupted or forward if point-in-time analysis is needed.
  • Real-time cloning at scale: ONTAP FlexClone technology can create instant clones of vector index stores to safely make uniquely relevant data instantly available for different queries for different users, without impacting the core production data.

“GenAI is a tidal wave of opportunity for the companies that can effectively apply their data to their industry,” said Miles Ward, CTO at SADA, An Insight Company. “At SADA we are fired up about pairing our extensive expertise with NetApp and Vertex AI to help customers accelerate their AI journeys. Why generate uninformed chats when you could generate unique, specific, relevant insights?”

The GenAI toolkit will be available as a public preview within the second half of 2024.

To learn more about the Flex service level for NetApp Volumes or the GenAI toolkit reference architecture for Vertex AI, visit the NetApp booth #1231 at the Google Cloud Next 2024 conference running from April 9-11 at Mandalay Bay in Las Vegas.

Additional Resources

About NetApp

NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410415954/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye